⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

SUN PHARMACEUTICAL INDUSTRIES INC: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx

DrugsSource: FDA (drug) · Date: 2026-06-17

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Sun Pharmaceutical Industries

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
SUN PHARMACEUTICAL INDUSTRIES INC
Product
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.
Reason / hazard
Presence of Particulate matter: Particulate matter identified as glass.
Classification
Class I
Status
Ongoing
Distribution / sold at
U.S. Nationwide
Recall initiated
2026-05-12
Code info
Lot HAG2581B, expires: 05/31/2027
Product quantity
675 vials
Voluntary mandated
Voluntary: Firm initiated
City
Princeton
State
NJ
Country
United States
Event id
98921
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.